<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00559442</url>
  </required_header>
  <id_info>
    <org_study_id>S-169/2007</org_study_id>
    <nct_id>NCT00559442</nct_id>
  </id_info>
  <brief_title>Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Hypoxic Pulmonary Vasoconstriction</brief_title>
  <official_title>Susceptibility to High Altitude Pulmonary Edema in Subjects With Increased Pulmonary Artery Pressure During Exercise in Normoxia and at Rest in Hypoxia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heidelberg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heidelberg University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been shown, that subjects susceptible to high altitude pulmonary edema (HAPE)are
      characterized by an abnormal increase of pulmonary artery pressure at rest in hypoxia and
      during exercise in normoxia. This abnormal rise of pulmonary artery pressure has also been
      observed in about 10 % of otherwise healthy subjects without prior altitude exposure. The aim
      of the study is to investigate the susceptibility to HAPE in unacclimatized subjects with
      abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise in
      normoxia after rapid ascent to high altitude (4559 m).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2007</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">December 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of HAPE after rapid ascent to 4559 m</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time course of pulmonary artery pressure</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessment of right ventricular function by echocardiography</measure>
    <time_frame>during the 48 h stay at altitude</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>High Altitude Pulmonary Edema</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>high altitude exposure without prior acclimatization</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Altitude Exposure:</intervention_name>
    <description>rapid ascent to Margherita Hut (4559 m) within 24 h</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  abnormal increase of pulmonary artery pressure at rest in hypoxia and during exercise
             in normoxia

          -  ability to climb Margherita Hut

        Exclusion Criteria:

          -  Birth at or above 1500 m altitude

          -  any cardiovascular or pulmonary disease

          -  Infection disease

          -  Intake of drugs, in particular Acetazolamide, Nifedipine, corticosteroids or
             PDE-5-inhibitors.

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christoph Dehnert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ekkehard Gr√ºnig, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Heidelberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sports Medicine, University Hospital</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 15, 2007</study_first_submitted>
  <study_first_submitted_qc>November 15, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 16, 2007</study_first_posted>
  <last_update_submitted>September 5, 2013</last_update_submitted>
  <last_update_submitted_qc>September 5, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 6, 2013</last_update_posted>
  <responsible_party>
    <name_title>Internal Medicine VII, Sports Medicine</name_title>
    <organization>Medical Clinic, University Hospital of Heidelberg</organization>
  </responsible_party>
  <keyword>high altitude pulmonary edema</keyword>
  <keyword>hypoxic pulmonary vasoconstriction</keyword>
  <keyword>right ventricular function</keyword>
  <keyword>hypoxia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Altitude Sickness</mesh_term>
    <mesh_term>Pulmonary Edema</mesh_term>
    <mesh_term>Hypertension, Pulmonary</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

